Everest Organics launches 'Posaconazole' API
Posaconazole is a triazole antifungal agent indicated for treating mucormycosis patients
Posaconazole is a triazole antifungal agent indicated for treating mucormycosis patients
The project will be instrumental in enhancing the company's API manufacturing capacity and global reach
The company has received final approval from the Department of Pharmaceuticals, Government of India, for foreign investment under applicable regulations
The company offers customized formulations tailored to align with each brand’s identity and consumer needs
Dr. Benjamin Bechem, already leading WeylChem Organica and European custom manufacturing sales
The CDMO business will be structured into three new business platforms designed to create a unified organization: Integrated Biologics, Advanced Synthesis, and Specialized Modalities
The product will be marketed by Dr. Reddy's
Hospital business revenues increase 13.9% to Rs. 1,655 crore
Revenue growth was fueled by higher volumes and contributions from both existing and new centres
Subscribe To Our Newsletter & Stay Updated